PI
MDCO

Putnam Investments’s Medicines Co MDCO Stock Holding History

Putnam Investments’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,673,357
Closed -$83.7M – 965
2019
Q3 		$83.7M Sell
1,673,357
-90,666
-5% -$3.62M 0.19% 133
2019
Q2 		$64.3M Buy
1,764,023
+106,535
+6% +$3.48M 0.14% 150
2019
Q1 		$46.3M Sell
1,657,488
-151,201
-8% -$3.56M 0.11% 172
2018
Q4 		$34.6M Sell
1,808,689
-63,236
-3% -$1.47M 0.09% 176
2018
Q3 		$56M Sell
1,871,925
-379,306
-17% -$14.3M 0.12% 158
2018
Q2 		$82.6M Sell
2,251,231
-268,913
-11% -$8.74M 0.19% 136
2018
Q1 		$83M Buy
2,520,144
+441,290
+21% +$13.8M 0.19% 129
2017
Q4 		$56.8M Buy
2,078,854
+578,556
+39% +$17.8M 0.13% 161
2017
Q3 		$55.6M Buy
1,500,298
+527,944
+54% +$19.5M 0.13% 155
2017
Q2 		$37M Buy
972,354
+839,577
+632% +$37.4M 0.09% 199
2017
Q1 		$6.49M Buy
132,777
+84,473
+175% +$3.85M 0.02% 501
2016
Q4 		$1.64M Sell
48,304
-197,096
-80% -$6.99M ﹤0.01% 892
2016
Q3 		$9.26M Sell
245,400
-36,105
-13% -$1.36M 0.02% 392
2016
Q2 		$9.47M Buy
281,505
+74,999
+36% +$2.64M 0.02% 424
2016
Q1 		$6.56M Buy
206,506
+109
+0.1% +$3.56K 0.02% 541
2015
Q4 		$7.71M Buy
206,397
+188
+0.1% +$7.11K 0.02% 535
2015
Q3 		$7.83M Sell
206,209
-1,012,126
-83% -$35.5M 0.02% 512
2015
Q2 		$34.9M Sell
1,218,335
-51,954
-4% -$1.45M 0.07% 249
2015
Q1 		$35.6M Sell
1,270,289
-42,749
-3% -$1.2M 0.07% 247
2014
Q4 		$36.3M Sell
1,313,038
-672,618
-34% -$16.7M 0.07% 250
2014
Q3 		$44.3M Sell
1,985,656
-571,205
-22% -$14.5M 0.09% 197
2014
Q2 		$74.3M Buy
2,556,861
+2,111,920
+475% +$56.4M 0.16% 145
2014
Q1 		$12.6M Buy
444,941
+376,514
+550% +$12.5M 0.03% 419
2013
Q4 		$2.64M Sell
68,427
-91,614
-57% -$3.28M 0.01% 970
2013
Q3 		$5.37M Sell
160,041
-201,817
-56% -$6.43M 0.01% 677
2013
Q2 		$11.1M Buy
+361,858
New +$12.1M 0.03% 394

Other funds holding MDCO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Putnam Investments's MDCO Position: Q4 2019 in Review

Putnam Investments sold out of Medicines Co (MDCO) in Q4 2019, closing a stake of 1,673,357 shares — an estimated $83.7M sold.

Putnam Investments first reported a position in MDCO in Q2 2013 and held it in 26 quarters. The position peaked at $83.7M in Q3 2019. 284 funds tracked by Wall St. Rank hold MDCO as of Q4 2019.

  • Putnam Investments reported no remaining Medicines Co position as of Q4 2019 after selling out during the quarter.
  • Putnam Investments sold 1,673,357 Medicines Co shares in Q4 2019, an estimated $83.7M.
  • Putnam Investments first reported a position in Medicines Co in Q2 2013 and held it in 26 quarters.
  • Putnam Investments's Medicines Co position peaked at $83.7M in Q3 2019.
  • 284 funds tracked by Wall St. Rank held Medicines Co as of Q4 2019.

Based on Putnam Investments's 13F filing for Q4 2019, filed 14 Feb 2020.